Literature DB >> 6450241

Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.

F V Chisari, M S Bieber, C A Josepho, C Xavier, D S Anderson.   

Abstract

Cytotoxic effector cell responsiveness to host and/or virus-determined hepatocyte surface membrane antigens has been postulated as an important pathogenetic determinant of hepatocellular injury in hepatitis B virus infection. Assuming that such effector cell populations would be detectable in peripheral blood, the present study was designed to examine 2 questions: first, whether target cells that normally express liver-specific protein (LSP) and hepatitis B surface antigen (HBsAg) are selectively destroyed by peripheral blood effector cells from patients with viral hepatitis; second, whether cytotoxic effector cell function emerges coincident with the development of defective suppressor cell activity in the same patients. No evidence of increased HBsAg or LSP specific cytotoxic effector cell activity was found in the peripheral blood natural killer (NK) or T killer cell populations of patients with acute or chronic viral hepatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6450241

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Natural killer activity in patients with acute viral hepatitis.

Authors:  L Chemello; M Mondelli; F Bortolotti; E Schiavon; P Pontisso; A Alberti; E G Rondanelli; G Realdi
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  The relationship between liver-specific lipoprotein and the hepatocyte plasma membrane.

Authors:  W N Bartholomaeus; N R Swanson; W D Reed; H L O'Donoghue; D Foti; J M Papadimitriou
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

3.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

4.  Increased thymic hormone responsive suppressor T lymphocyte function in chronic active hepatitis.

Authors:  M G Mutchnick; J A Schaffner; J A Prieto; F E Weller; A L Goldstein
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

5.  Lymphocyte cytotoxicity for autologous hepatocytes.

Authors:  M Mondelli; A L Eddleston
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

6.  Lymphocyte phenotype and function in pseudolymphoma associated with Sjögren's syndrome.

Authors:  R I Fox; T C Adamson; S Fong; C A Robinson; E L Morgan; J A Robb; F V Howell
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Diminished active T rosette levels and increased spontaneous B lymphocyte blastogenesis in hepatitis B virus positive chronic active hepatitis.

Authors:  G Budillon; G Scala; C D'Onofrio; S Cassano; F De Ritis
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.

Authors:  D Shouval; J R Wands; V R Zurawski; K J Isselbacher; D A Shafritz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Cellular immunity to the hepatitis B virion in acute hepatitis type B.

Authors:  G Fattovich; A Alberti; C Crivellaro; P Pontisso; F Noventa; G Realdi
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B.

Authors:  Y Ito; S Kakumu; K Yoshioka; T Wakita; T Ishikawa; K Koike
Journal:  Gastroenterol Jpn       Date:  1993-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.